Caveolae Control Contractile Tension for Epithelia to Eliminate Tumor Cells.


Journal

Developmental cell
ISSN: 1878-1551
Titre abrégé: Dev Cell
Pays: United States
ID NLM: 101120028

Informations de publication

Date de publication:
06 07 2020
Historique:
received: 23 08 2019
revised: 17 03 2020
accepted: 01 05 2020
pubmed: 3 6 2020
medline: 2 1 2021
entrez: 3 6 2020
Statut: ppublish

Résumé

Epithelia are active materials where mechanical tension governs morphogenesis and homeostasis. But how that tension is regulated remains incompletely understood. We now report that caveolae control epithelial tension and show that this is necessary for oncogene-transfected cells to be eliminated by apical extrusion. Depletion of caveolin-1 (CAV1) increased steady-state tensile stresses in epithelial monolayers. As a result, loss of CAV1 in the epithelial cells surrounding oncogene-expressing cells prevented their apical extrusion. Epithelial tension in CAV1-depleted monolayers was increased by cortical contractility at adherens junctions. This reflected a signaling pathway, where elevated levels of phosphoinositide-4,5-bisphosphate (PtdIns(4,5)P

Identifiants

pubmed: 32485139
pii: S1534-5807(20)30358-0
doi: 10.1016/j.devcel.2020.05.002
pii:
doi:

Substances chimiques

Cav1 protein, mouse 0
Caveolin 1 0
FMNL2 protein, mouse 0
Formins 0
Oncogene Proteins 0
Phosphatidylinositol 4,5-Diphosphate 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-91.e7

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Jessica L Teo (JL)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Guillermo A Gomez (GA)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA 5000, Australia.

Saroja Weeratunga (S)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Elizabeth M Davies (EM)

Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.

Ivar Noordstra (I)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Srikanth Budnar (S)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Hiroko Katsuno-Kambe (H)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Meagan J McGrath (MJ)

Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.

Suzie Verma (S)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Vanesa Tomatis (V)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Bipul R Acharya (BR)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Lakshmi Balasubramaniam (L)

Institut Jacques Monod, Université de Paris, CNRS UMR 7592, 75013 Paris, France.

Rachel M Templin (RM)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Kerrie-Ann McMahon (KA)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Yoke Seng Lee (YS)

Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Brisbane, QLD 4102, Australia.

Robert J Ju (RJ)

The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Brisbane, QLD 4102, Australia.

Samantha J Stebhens (SJ)

The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Brisbane, QLD 4102, Australia.

Benoit Ladoux (B)

Institut Jacques Monod, Université de Paris, CNRS UMR 7592, 75013 Paris, France.

Christina A Mitchell (CA)

Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.

Brett M Collins (BM)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Robert G Parton (RG)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia; Centre for Microscopy and Microanalysis, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia. Electronic address: r.parton@uq.edu.au.

Alpha S Yap (AS)

Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia. Electronic address: a.yap@uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH